TrialScientific reports2023

Part two: an unblinded, parallel, randomized study to assess nicotine pharmacokinetics of four Vuse Solo ENDS flavors in smokers.

Brian M Keyser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.